BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20108624)

  • 1. Examination of transforming growth factor beta1 expression in the serum and tumor tissue of gastric cancer.
    Suda A; Saito N; Seshimo A; Kameoka S; Kobayashi M
    Int Surg; 2009; 94(2):182-8. PubMed ID: 20108624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
    Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of transforming growth factor beta1 are significantly correlated with venous invasion in patients with gastric cancer.
    Lin Y; Kikuchi S; Obata Y; Yagyu K;
    J Gastroenterol Hepatol; 2006 Feb; 21(2):432-7. PubMed ID: 16509870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers.
    Coban S; Yüksel O; Koçkar MC; Köklü S; Basar O; Tutkak H; Ormeci N
    Hepatogastroenterology; 2007; 54(77):1472-6. PubMed ID: 17708279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer.
    Xiangming C; Natsugoe S; Takao S; Hokita S; Ishigami S; Tanabe G; Baba M; Kuroshima K; Aikou T
    Clin Cancer Res; 2001 Feb; 7(2):277-82. PubMed ID: 11234879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patients.
    Hawinkels LJ; Verspaget HW; van Duijn W; van der Zon JM; Zuidwijk K; Kubben FJ; Verheijen JH; Hommes DW; Lamers CB; Sier CF
    Br J Cancer; 2007 Aug; 97(3):398-404. PubMed ID: 17637685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.
    Natsugoe S; Xiangming C; Matsumoto M; Okumura H; Nakashima S; Sakita H; Ishigami S; Baba M; Takao S; Aikou T
    Clin Cancer Res; 2002 Jun; 8(6):1838-42. PubMed ID: 12060625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
    Yoo YA; Kang MH; Kim JS; Oh SC
    Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor C (VEGF-C) expression in pT2 gastric cancer.
    Tsutsumi S; Kuwano H; Shimura T; Morinaga N; Mochiki E; Asao T
    Hepatogastroenterology; 2005; 52(62):629-32. PubMed ID: 15816493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
    Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
    Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
    Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
    Picon A; Gold LI; Wang J; Cohen A; Friedman E
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival.
    Vagenas K; Spyropoulos C; Gavala V; Tsamandas AC
    J Surg Res; 2007 May; 139(2):182-8. PubMed ID: 17270215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome.
    Okano H; Shinohara H; Miyamoto A; Takaori K; Tanigawa N
    Clin Cancer Res; 2004 Oct; 10(20):6938-45. PubMed ID: 15501972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-beta 1) increase invasion rate of tumor cells: a population study.
    Casey TM; Eneman J; Crocker A; White J; Tessitore J; Stanley M; Harlow S; Bunn JY; Weaver D; Muss H; Plaut K
    Breast Cancer Res Treat; 2008 Jul; 110(1):39-49. PubMed ID: 17674196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
    Shariat SF; Menesses-Diaz A; Kim IY; Muramoto M; Wheeler TM; Slawin KM
    Urology; 2004 Jun; 63(6):1191-7. PubMed ID: 15183988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.